Dipyridamole dosage and administration: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Dipyridamole}} {{CMG}}; {{AE}} {{SS}} ==Dosage and Administration== Adjunctive Use in Prophylaxis of Thromboembolism after Cardiac Valve Replacement. The reco...")
 
 
Line 1: Line 1:
__NOTOC__
#REDIRECT [[Dipyridamole#Adult Indications and Dosage]]
{{Dipyridamole}}
{{CMG}}; {{AE}} {{SS}}
 
==Dosage and Administration==
Adjunctive Use in Prophylaxis of [[Thromboembolism]] after Cardiac Valve Replacement. The recommended dose is 75-100 mg four times daily as an adjunct to the usual [[warfarin]] therapy. Please note that [[aspirin]] is not to be administered concomitantly with coumarin anticoagulants.<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = PERSANTINE (DIPYRIDAMOLE) TABLET, COATED [BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ca68879c-0214-4d7c-93b0-bdaf8ef23f8e | publisher =  | date =  | accessdate = 7 February 2014 }}</ref>
 
==References==
 
{{Reflist|2}}
 
[[Category:Antiplatelet drugs]]
[[Category:Cardiovascular Drugs]]
[[Category:Drugs]]
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}

Latest revision as of 22:32, 21 July 2014